United Kingdom · Question · Written question
HL HL4478
Streptococcus: Screening
Introduced
21 December 2022
Last action
5 January 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
5 January 2023
Summary
To ask His Majesty's Government what assessment they have made of (1) the medical efficacy and value to users of commercial Strep A tests, and (2) any extra costs that might result for the NHS as a result of such tests.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 December 2022
Written question
To ask His Majesty's Government what assessment they have made of (1) the medical efficacy and value to users of commercial Strep A tests, and (2) any extra costs that might result for the NHS as a result of such tests.
Source: Lords
5 January 2023
Answer
Rapid tests for Group A Streptococcus (Strep A) are not currently recommended by the National Institute for Health and Care Excellence (NICE) for individuals aged five years old and over presenting with a sore throat. However, in response to the ongoing n...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-12-21/HL4478
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1563814
- uk · wq-1563814 · source updated 5 January 2023